"In Vivo" Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization (PLAVASC)
Primary Purpose
Carotid Artery Disease, Plaque Neovascularization
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Contrast enhanced ultrasound of the carotid plaque
Dynamic contrast-enhanced carotid plaque MRI
Sponsored by
About this trial
This is an interventional diagnostic trial for Carotid Artery Disease
Eligibility Criteria
Inclusion Criteria:
- Asymptomatic 50-70% carotid artery stenosis on Doppler ultrasound
- Asymptomatic >70% carotid artery stenosis on Doppler ultrasound (no surgical indication)
- Signed informed consent
Exclusion Criteria:
- Non atherosclerotic occlusive disease
- Prior carotid endarterectomy on the site of the index carotid artery
- Contraindications for MRI and CE MRI (history of hypersensitivity to gadolinium salt, pacemaker or vascular clip implantation, implantation of any metallic device, severe claustrophobic reactions)
- Contraindications to CEUS (hypersensitivity to Sonovue compounds, acute coronary syndromes, acute heart failure, heart failure in NYHA class III or IV, severe arrhythmias, known right-to-left cardiac shunt, severe pulmonary hypertension, uncontrolled arterial hypertension, acute distress respiratory syndrome)
- Short-term life-threatening pathology (life expectancy < 6 months)
- Physically unable to participate in the study
- Compliance not guaranteed
- Pregnancy
Sites / Locations
- Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Imaging of carotid plaque
Arm Description
Patient undergo contrast enhanced ultrasound of the carotid plaque and dynamic contrast-enhanced carotid plaque MRI
Outcomes
Primary Outcome Measures
Plaque neovascularization grading and quantification (assessment by DCE-MRI)
Contrast enhanced ultrasound plaque neovascularization grading , correlated to plaque neovascularization quantitative assessment by DCE-MRI.
Secondary Outcome Measures
Full Information
NCT ID
NCT02321410
First Posted
November 26, 2014
Last Updated
November 20, 2017
Sponsor
Ospedale San Giovanni Bellinzona
1. Study Identification
Unique Protocol Identification Number
NCT02321410
Brief Title
"In Vivo" Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization
Acronym
PLAVASC
Official Title
Plaque Neovascularization Assessment by Contrast Ultrasounds and Plaque Magnetic Resonance: "in Vivo" Comparison in Human Carotid Atherosclerosis
Study Type
Interventional
2. Study Status
Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
February 2014 (undefined)
Primary Completion Date
April 2016 (Actual)
Study Completion Date
April 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ospedale San Giovanni Bellinzona
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Atherosclerosis may initiate early in life and takes years to progress. This contrasts to the abrupt coronary or cerebrovascular events occurring following the transition from a stable to an unstable atherosclerotic plaque. The causes of this discontinuity of the disease are complex and probably multiple. There is increasing evidence that, besides inflammation, neovascularisation of atherosclerotic plaques and intra-plaque hemorrhages play an important role in plaque instability ending-up frequently in acute thrombotic occlusion or distal embolisation of athero-thrombotic material associated with heart attack or stroke. Contrast-enhanced Ultrasound, is a bed-side non-invasive technique, which allows to enhance microvascular structures and to visualize the adventitia and intraplaque vascularization. Dynamic contrast-enhanced plaque MRI (DCE-MRI) which has also been evaluated for in vivo detection and quantification of plaque neovascularity. Together with the presence of a large lipid-rich core, thin fibrous cap, positive remodeling and active inflammatory infiltrate, plaque neovascularisation is considered a valid marker of high-risk (or vulnerable) plaque as demonstrated in histopathological studies using microvessel density.
Aim of the study is to assess and validate the value of contrast enhanced ultrasound (CEUS), a bed-side technique, in detecting plaque neovascularisation and compare it with the quantitative assessment by DCE-MRI in carotis atherosclerosis.
A group of 30 patients with asymptomatic carotid atherosclerosis (> 50% stenosis on Doppler ultrasound) will undergo Carotid Duplex ultrasounds and CEUS. High-resolution plaque MRI and DCE-MRI will be performed in the same patients and will be analyzed by two separate operators blinded to the results of the CEUS in order to detect the efficacy of CEUS when compared with in vivo DCE-MRI, as the standard of reference.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carotid Artery Disease, Plaque Neovascularization
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Imaging of carotid plaque
Arm Type
Other
Arm Description
Patient undergo contrast enhanced ultrasound of the carotid plaque and dynamic contrast-enhanced carotid plaque MRI
Intervention Type
Other
Intervention Name(s)
Contrast enhanced ultrasound of the carotid plaque
Intervention Description
visual grading of neovessel
Intervention Type
Other
Intervention Name(s)
Dynamic contrast-enhanced carotid plaque MRI
Intervention Description
quantitative analysis of gadolinium enchantment in a region of interest
Primary Outcome Measure Information:
Title
Plaque neovascularization grading and quantification (assessment by DCE-MRI)
Description
Contrast enhanced ultrasound plaque neovascularization grading , correlated to plaque neovascularization quantitative assessment by DCE-MRI.
Time Frame
Baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Asymptomatic 50-70% carotid artery stenosis on Doppler ultrasound
Asymptomatic >70% carotid artery stenosis on Doppler ultrasound (no surgical indication)
Signed informed consent
Exclusion Criteria:
Non atherosclerotic occlusive disease
Prior carotid endarterectomy on the site of the index carotid artery
Contraindications for MRI and CE MRI (history of hypersensitivity to gadolinium salt, pacemaker or vascular clip implantation, implantation of any metallic device, severe claustrophobic reactions)
Contraindications to CEUS (hypersensitivity to Sonovue compounds, acute coronary syndromes, acute heart failure, heart failure in NYHA class III or IV, severe arrhythmias, known right-to-left cardiac shunt, severe pulmonary hypertension, uncontrolled arterial hypertension, acute distress respiratory syndrome)
Short-term life-threatening pathology (life expectancy < 6 months)
Physically unable to participate in the study
Compliance not guaranteed
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Augusto Gallino, Prof. MD
Organizational Affiliation
Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mattia Cattaneo, MD
Organizational Affiliation
Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona
Official's Role
Study Chair
Facility Information:
Facility Name
Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona
City
Bellinzona
State/Province
Canton Ticino
ZIP/Postal Code
6500
Country
Switzerland
12. IPD Sharing Statement
Citations:
PubMed Identifier
27752526
Citation
Cattaneo M, Staub D, Porretta AP, Gallino JM, Santini P, Limoni C, Wyttenbach R, Gallino A. Data on consistency among different methods to assess atherosclerotic plaque echogenicity on standard ultrasound and intraplaque neovascularization on contrast-enhanced ultrasound imaging in human carotid artery. Data Brief. 2016 Oct 3;9:563-567. doi: 10.1016/j.dib.2016.09.041. eCollection 2016 Dec.
Results Reference
result
PubMed Identifier
27597156
Citation
Cattaneo M, Staub D, Porretta AP, Gallino JM, Santini P, Limoni C, Wyttenbach R, Gallino A. Contrast-enhanced ultrasound imaging of intraplaque neovascularization and its correlation to plaque echogenicity in human carotid arteries atherosclerosis. Int J Cardiol. 2016 Nov 15;223:917-922. doi: 10.1016/j.ijcard.2016.08.261. Epub 2016 Aug 16.
Results Reference
result
PubMed Identifier
31661690
Citation
Cattaneo M, Sun J, Staub D, Xu D, Gallino JM, Santini P, Porretta AP, Yuan C, Balu N, Arnold M, Froio A, Limoni C, Wyttenbach R, Gallino A. Imaging of Carotid Plaque Neovascularization by Contrast-Enhanced Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Cerebrovasc Dis. 2019;48(3-6):140-148. doi: 10.1159/000504042. Epub 2019 Oct 29.
Results Reference
derived
Learn more about this trial
"In Vivo" Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization
We'll reach out to this number within 24 hrs